Novartis
NVS
NVS
1,361 hedge funds and large institutions have $16.1B invested in Novartis in 2025 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 488 increasing their positions, 472 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more repeat investments, than reductions
Existing positions increased: 488 | Existing positions reduced: 472
0.27% less ownership
Funds ownership: 6.58% → 6.31% (-0.27%)
19% less call options, than puts
Call options by funds: $269M | Put options by funds: $331M
Holders
1,361
Holding in Top 10
17
Calls
$269M
Puts
$331M
Top Buyers
| 1 | +$60.9M | |
| 2 | +$57.3M | |
| 3 | +$56.8M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$55M |
| 5 |
Millennium Management
New York
|
+$50.5M |
Top Sellers
| 1 | -$206M | |
| 2 | -$165M | |
| 3 | -$142M | |
| 4 |
Goldman Sachs
New York
|
-$135M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119M |
